NEW YORK (GenomeWeb) – Illumina announced today that it has launched its noninvasive prenatal test, VeriSeq NIPT, as a CE-marked in vitro diagnostic in Europe. The test screens for trisomies 21, 18, and 13, as well as some sex chromosomal disorders at 10 weeks' gestation.